T025 is a highly potent and orally available inhibitor of Cdc2-like kinase (CLK)(Kds of 4.8, 0.096, 6.5, and 0.61 nM for CLK1, CLK2, CLK3, and CLK4, respectively).

2407433-00-3

C21H18N8

382.42

T025

DMSO:8.25 mg/mL (21.57 mM),Need ultrasonic
Powder: -20°C for 3 years
In solvent: -80°C for 2 years